IP Verse

Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab - EP2766040

PATENT ANALYSIS

Patent Details

Grant Date
May 15, 2019
Company
F. HOFFMANN-LA ROCHE AG
Oppositions

DR. H. ULRICH DORRIES

DR. REDDY'S LABORATORIES LIMITED

EUROPEAN OPPOSITIONS LIMITED

GILL JENNINGS & EVERY LLP

J A KEMP LLP

KONIG SZYNKA TILMANN VON RENESSE

LEDL, ANDREAS

POHLMAN, SANDRA M.

ROTH, CARLA

More patents of F. Hoffmann-La Roche Ag

EP3257564

EP3294770

EP3870594

Want to monitor this patent?

Feel free to send us a message here and we will get back to you